Skip to main content

Table 2 Variable comparison between groups 3 months’ follow-up

From: Effects and mechanism of moderate aerobic exercise on impaired fasting glucose improvement

Variables Active (n = 52) Controlled (n = 56)
Age (years) 43.7 ± 5.2 44.9 ± 6.0
Male, n (%) 28 (53.8) 31 (55.4)
BMI (kg/m2) 23.1 ± 3.5 24.2 ± 4.6
Overweight, n (%)* 5 (9.6) 10 (17.9)
Obese, n (%) 5 (9.6) 5 (8.9)
Waist circumference (cm) 81.2 ± 5.2 82.2 ± 7.6
Smoking, n (%) 18 (34.6) 18 (32.1)
Hypertension, n (%) 13 (25.0) 13 (23.2)
Dyslipidemia, n (%) 15 (28.8) 16 (28.6)
SBP (mmHg) 120.5 ± 11.7 122.4 ± 11.3
DBP (mmHg) 75.4 ± 7.8 75.1 ± 9.0
HR (bpm) 70.3 ± 8.3 73.1 ± 7.6
TG (mmol/L) 1.6 ± 0.3 1.8 ± 0.3
TC (mmol/L) 5.1 ± 0.5 5.5 ± 0.4
LDL-C (mmol/L) 3.2 ± 0.3 3.4 ± 0.4
HDL-C (mmol/L) 1.2 ± 0.2 1.1 ± 0.3
Lp(a) (mg/L)* 109.6 ± 10.7 121.3 ± 12.4
FBG (mmol/L) 6.0 ± 0.3 6.3 ± 0.5
HbA1c (%) 5.4 ± 0.4 5.6 ± 0.3
Cr (μmol/L) 95.4 ± 10.3 99.7 ± 9.2
BUN (mmol/L) 5.7 ± 1.1 5.9 ± 1.0
Hs-CRP (mg/L)* 3.4 ± 0.7 4.9 ± 1.1
ROCK2 activity (mg/mL)* 40.6 ± 5.3 53.3 ± 7.0
Fasting C-peptide level (nmol/L)* 0.89 ± 0.11 0.46 ± 0.10
Fasting insulin level (pmol/L)* 24.3 ± 4.6 19.7 ± 3.0
Aspirin, n (%) 29 (55.8) 30 (53.7)
ACEI, n (%) 10 (19.2) 9 (16.1)
ARB, n (%) 4 (7.7) 6 (10.7)
CCB, n (%) 5 (9.6) 4 (7.1)
Statins, n (%) 16 (30.8) 17 (30.4)
IFG, n (%)* 40 (76.9) 46 (82.1)
  1. *p < 0.05